Afya Limited Earnings Call Transcripts
Fiscal Year 2025
-
Delivered strong 2025 results with 12% revenue and 18% net income growth, robust cash flow, and a 19% EPS increase. 2026 guidance anticipates continued growth, with investments in technology and integration expected to impact margins.
-
Strong revenue and profit growth continued, with margin expansion and robust cash generation. Capital allocation remains flexible, balancing M&A, buybacks, and dividends, while tax rates are expected to rise due to new regulations.
-
The event outlined a strategy centered on integrating education, technology, and clinical practice, with strong financial guidance for 2025 and continued investment in innovation and digital solutions. The company leverages AI, expands its ecosystem, and maintains a leading market position through scale, differentiation, and disciplined execution.
-
Q2 and H1 2025 saw double-digit revenue and EBITDA growth, margin expansion, and strong cash flow, driven by robust performance across all segments and disciplined capital allocation. Guidance for 2025 is reaffirmed, with tax and competitive pressures being actively managed.
-
Net revenue rose 16% and adjusted EBITDA 24% year-over-year, with strong cash flow and margin expansion. Undergrad, continuing education, and medical practice solutions all posted growth, while new tax provisions and debt planning were addressed.
Fiscal Year 2024
-
Net revenue grew 15% year over year to BRL 3.3 billion, with adjusted EBITDA up 25% and net income up 60%. 2025 guidance projects continued growth, with a 20% dividend payout and ongoing M&A focus. Operational leverage and strong intake support margin expansion.
-
Q3 2024 saw 16% revenue growth and 25% adjusted EBITDA growth, with strong cash flow and stable net debt despite acquisitions. Medical student numbers and margins expanded, and M&A activity is expected to continue with lower multiples.
-
The event outlined a strategy centered on integrated medical education and digital solutions, driving strong growth through organic expansion, disciplined M&A, and innovation. High employability, robust cash generation, and a focus on social impact and reputation underpin long-term sustainability and leadership in the sector.
-
Q2 2024 saw double-digit revenue and EBITDA growth, margin expansion, and strong cash flow, driven by robust performance across all segments and successful integration of recent acquisitions. Updated 2024 guidance reflects higher revenue and EBITDA expectations.